{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:56:07Z","timestamp":1792151767562,"version":"4.4.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-162410"],"award-info":[{"award-number":["PJT-162410"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-197925"],"award-info":[{"award-number":["PJT-197925"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","award":["Investigator Award"],"award-info":[{"award-number":["Investigator Award"]}],"id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77900-7","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:29:49Z","timestamp":1792150189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6423-5093","authenticated-orcid":false,"given":"Diogo","family":"Pellegrina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Kiriy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"C. L. Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3684-2659","authenticated-orcid":false,"given":"Francesco","family":"Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrichetta","family":"Miletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0228-5503","authenticated-orcid":false,"given":"Zoe P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4019-2732","authenticated-orcid":false,"given":"Barbara","family":"Hernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre V.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atef","family":"Sahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlo","family":"Lutsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9100-1807","authenticated-orcid":false,"given":"Weerachai","family":"Jaratlerdsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6242-4269","authenticated-orcid":false,"given":"William J.","family":"Hutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Steven","family":"Bova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4753-9794","authenticated-orcid":false,"given":"Daniel S.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8969-2378","authenticated-orcid":false,"given":"Mark","family":"Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-3101","authenticated-orcid":false,"given":"Benedikt","family":"Brors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9583-6382","authenticated-orcid":false,"given":"G\u00e9raldine","family":"Cancel-Tassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall M.","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cussenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3676-5561","authenticated-orcid":false,"given":"Abraham","family":"Gihawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsehiwot G.","family":"Girma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4722-4207","authenticated-orcid":false,"given":"Vincent J.","family":"Gnanapragasam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-9723","authenticated-orcid":false,"given":"Anis A.","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2898-3363","authenticated-orcid":false,"given":"Housheng Hansen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddie Luidy L.","family":"Imada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8225-6541","authenticated-orcid":false,"given":"G. Maria","family":"Jakobsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2992-3162","authenticated-orcid":false,"given":"Chol-hee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7238-8604","authenticated-orcid":false,"given":"Francesca","family":"Khani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6329-5155","authenticated-orcid":false,"given":"Zsofia","family":"Kote-Jarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1347-7724","authenticated-orcid":false,"given":"Philippe","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5212-6850","authenticated-orcid":false,"given":"Gregory","family":"Leeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9674-8379","authenticated-orcid":false,"given":"Massimo","family":"Loda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramyar","family":"Molania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6090-1834","authenticated-orcid":false,"given":"Lucio R.","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5773-5620","authenticated-orcid":false,"given":"Tobias","family":"Rausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5374-890X","authenticated-orcid":false,"given":"Brian","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4902-5490","authenticated-orcid":false,"given":"Karina D.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0068-5957","authenticated-orcid":false,"given":"Sebastian","family":"Uhrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1242-513X","authenticated-orcid":false,"given":"Yaobo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1082-3871","authenticated-orcid":false,"given":"Takafumi N.","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5043-8033","authenticated-orcid":false,"given":"Claudio","family":"Zanettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Pan Prostate Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mangiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8646-2817","authenticated-orcid":false,"given":"Lena","family":"Voith von Voithenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7336-8071","authenticated-orcid":false,"given":"Luigi","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1102-8506","authenticated-orcid":false,"given":"Anthony T.","family":"Papenfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4840-1095","authenticated-orcid":false,"given":"Bernard","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-7280","authenticated-orcid":false,"given":"Vanessa M.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9557-4653","authenticated-orcid":false,"given":"Thorsten","family":"Schlomm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-9544","authenticated-orcid":false,"given":"Robert G.","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0610-1289","authenticated-orcid":false,"given":"Christopher M.","family":"Hovens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3698-6241","authenticated-orcid":false,"given":"Ros A.","family":"Eeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5792-3901","authenticated-orcid":false,"given":"Clarissa","family":"Gerhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-467X","authenticated-orcid":false,"given":"Geoff","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7664-4257","authenticated-orcid":false,"given":"Andreas J.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7572-3196","authenticated-orcid":false,"given":"David C.","family":"Wedge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-5524","authenticated-orcid":false,"given":"Joachim","family":"Weischenfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2299-2309","authenticated-orcid":false,"given":"J\u00fcri","family":"Reimand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"77900_CR1","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James, N. D. et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet 403, 1683\u20131722 (2024).","journal-title":"Lancet"},{"key":"77900_CR2","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","volume":"34","author":"C Gerhauser","year":"2018","unstructured":"Gerhauser, C. et al. Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories. Cancer Cell 34, 996\u20131011.e8 (2018).","journal-title":"Cancer Cell"},{"key":"77900_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13084-7","volume":"10","author":"LF van Dessel","year":"2019","unstructured":"van Dessel, L. F. et al. The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact. Nat. Commun. 10, 5251 (2019).","journal-title":"Nat. Commun."},{"key":"77900_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello, R. J. et al. Prostate cancer. Nat. Rev. Dis. Prim. 7, 9 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"77900_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"Cancer Genome Atlas Research Network","year":"2015","unstructured":"Cancer Genome Atlas Research Network The molecular taxonomy of primary prostate cancer. Cell 163, 1011\u20131025 (2015).","journal-title":"Cell"},{"key":"77900_CR6","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/ng.3315","volume":"47","author":"PC Boutros","year":"2015","unstructured":"Boutros, P. C. et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat. Genet. 47, 736\u2013745 (2015).","journal-title":"Nat. Genet."},{"key":"77900_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41588-018-0086-z","volume":"50","author":"DC Wedge","year":"2018","unstructured":"Wedge, D. C. et al. Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. Nat. Genet. 50, 682\u2013692 (2018).","journal-title":"Nat. Genet."},{"key":"77900_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","volume":"50","author":"J Armenia","year":"2018","unstructured":"Armenia, J. et al. The long tail of oncogenic drivers in prostate cancer. Nat. Genet. 50, 645\u2013651 (2018).","journal-title":"Nat. Genet."},{"key":"77900_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature20788","volume":"541","author":"M Fraser","year":"2017","unstructured":"Fraser, M. et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature 541, 359\u2013364 (2017).","journal-title":"Nature"},{"key":"77900_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26489-0","volume":"12","author":"M Fraser","year":"2021","unstructured":"Fraser, M. et al. Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse. Nat. Commun. 12, 6248 (2021).","journal-title":"Nat. Commun."},{"key":"77900_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","volume":"578","author":"E Rheinbay","year":"2020","unstructured":"Rheinbay, E. et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578, 102\u2013111 (2020).","journal-title":"Nature"},{"key":"77900_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","unstructured":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium Pan-cancer analysis of whole genomes. Nature 578, 82\u201393 (2020).","journal-title":"Nature"},{"key":"77900_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"77900_CR14","unstructured":"Jakobsdottir, G. M. et al. The Pan Prostate Cancer Group Dataset - genomic, transcriptomic and methylation data for clinical discovery. Sci. Data (2026)."},{"key":"77900_CR15","doi-asserted-by":"crossref","unstructured":"Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191\u2013196 (2010).","DOI":"10.1038\/nature08658"},{"key":"77900_CR16","doi-asserted-by":"crossref","unstructured":"Zhu, H. et al. Candidate cancer driver mutations in distal regulatory elements and long-range chromatin interaction networks. Mol. Cell 77, 1307\u20131321 (2020).","DOI":"10.1016\/j.molcel.2019.12.027"},{"key":"77900_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"77900_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5114","volume":"5","author":"G Strona","year":"2014","unstructured":"Strona, G., Nappo, D., Boccacci, F., Fattorini, S. & San-Miguel-Ayanz, J. A fast and unbiased procedure to randomize ecological binary matrices with fixed row and column totals. Nat. Commun. 5, 4114 (2014).","journal-title":"Nat. Commun."},{"key":"77900_CR19","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029\u20131041 e21 (2017).","journal-title":"Cell"},{"key":"77900_CR20","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/ng.3419","volume":"47","author":"MM Pomerantz","year":"2015","unstructured":"Pomerantz, M. M. et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat. Genet. 47, 1346\u20131351 (2015).","journal-title":"Nat. Genet."},{"key":"77900_CR21","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1158\/0008-5472.CAN-21-2056","volume":"81","author":"JR Hawley","year":"2021","unstructured":"Hawley, J. R. et al. Reorganization of the 3D genome pinpoints noncoding drivers of primary prostate tumors. Cancer Res. 81, 5833\u20135848 (2021).","journal-title":"Cancer Res."},{"key":"77900_CR22","doi-asserted-by":"crossref","unstructured":"Corces, M. R. et al. The chromatin accessibility landscape of primary human cancers. Science 362, (2018).","DOI":"10.1126\/science.362.6413.415-k"},{"key":"77900_CR23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41588-020-0664-8","volume":"52","author":"MM Pomerantz","year":"2020","unstructured":"Pomerantz, M. M. et al. Prostate cancer reactivates developmental epigenomic programs during metastatic progression. Nat. Genet. 52, 790\u2013799 (2020).","journal-title":"Nat. Genet."},{"key":"77900_CR24","first-page":"3221","volume":"62","author":"RA Finch","year":"2002","unstructured":"Finch, R. A. et al. Mdmx is a negative regulator of p53 activity in vivo. Cancer Res. 62, 3221\u20133225 (2002).","journal-title":"Cancer Res."},{"key":"77900_CR25","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.1421415111","volume":"111","author":"B He","year":"2014","unstructured":"He, B. et al. GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex. Proc. Natl. Acad. Sci. USA 111, 18261\u201318266 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77900_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrurol.2016.225","volume":"14","author":"V Rodriguez-Bravo","year":"2017","unstructured":"Rodriguez-Bravo, V. et al. The role of GATA2 in lethal prostate cancer aggressiveness. Nat. Rev. Urol. 14, 38\u201348 (2017).","journal-title":"Nat. Rev. Urol."},{"key":"77900_CR27","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/bjc.2014.13","volume":"110","author":"S Merson","year":"2014","unstructured":"Merson, S. et al. Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer. Br. J. Cancer 110, 1655\u20131662 (2014).","journal-title":"Br. J. Cancer"},{"key":"77900_CR28","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/sj.bjc.6601127","volume":"89","author":"J Edwards","year":"2003","unstructured":"Edwards, J., Krishna, N. S., Grigor, K. M. & Bartlett, J. M. S. Androgen receptor gene amplification and protein expression in hormone-refractory prostate cancer. Br. J. Cancer 89, 552\u2013556 (2003).","journal-title":"Br. J. Cancer"},{"key":"77900_CR29","first-page":"3550","volume":"61","author":"MJ Linja","year":"2001","unstructured":"Linja, M. J. et al. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res. 61, 3550\u20133555 (2001).","journal-title":"Cancer Res."},{"key":"77900_CR30","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644\u2013648 (2005).","journal-title":"Science"},{"key":"77900_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ccr.2013.01.002","volume":"23","author":"J Weischenfeldt","year":"2013","unstructured":"Weischenfeldt, J. et al. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell 23, 159\u2013170 (2013).","journal-title":"Cancer Cell"},{"key":"77900_CR32","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696\u2013705 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"77900_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1101\/gad.292516.116","volume":"31","author":"JWC Leung","year":"2017","unstructured":"Leung, J. W. C. et al. ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. Genes Dev. 31, 260\u2013274 (2017).","journal-title":"Genes Dev."},{"key":"77900_CR34","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/pros.21111","volume":"70","author":"SA Williams","year":"2010","unstructured":"Williams, S. A., Xu, Y., De Marzo, A. M., Isaacs, J. T. & Denmeade, S. R. Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA\/KLK2 double transgenic mice. Prostate 70, 788\u2013796 (2010).","journal-title":"Prostate"},{"key":"77900_CR35","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/pros.24038","volume":"80","author":"S Bonk","year":"2020","unstructured":"Bonk, S. et al. Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer. Prostate 80, 1097\u20131107 (2020).","journal-title":"Prostate"},{"key":"77900_CR36","doi-asserted-by":"publisher","first-page":"10361","DOI":"10.1158\/0008-5472.CAN-06-4758","volume":"67","author":"Y Chen","year":"2007","unstructured":"Chen, Y., Tang, Y., Wang, M.-T., Zeng, S. & Nie, D. Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Cancer Res. 67, 10361\u201310367 (2007).","journal-title":"Cancer Res."},{"key":"77900_CR37","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1210\/en.2010-0708","volume":"151","author":"B Zhang","year":"2010","unstructured":"Zhang, B. et al. Pregnane X receptor as a therapeutic target to inhibit androgen activity. Endocrinology 151, 5721\u20135729 (2010).","journal-title":"Endocrinology"},{"key":"77900_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41586-019-1347-4","volume":"571","author":"A Parolia","year":"2019","unstructured":"Parolia, A. et al. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer. Nature 571, 413\u2013418 (2019).","journal-title":"Nature"},{"key":"77900_CR39","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41586-022-05154-6","volume":"609","author":"W Jaratlerdsiri","year":"2022","unstructured":"Jaratlerdsiri, W. et al. African-specific molecular taxonomy of prostate cancer. Nature 609, 552\u2013559 (2022).","journal-title":"Nature"},{"key":"77900_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14367-0","volume":"11","author":"MA Reyna","year":"2020","unstructured":"Reyna, M. A. et al. Pathway and network analysis of more than 2500 whole cancer genomes. Nat. Commun. 11, 729 (2020).","journal-title":"Nat. Commun."},{"key":"77900_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13983-9","volume":"11","author":"M Paczkowska","year":"2020","unstructured":"Paczkowska, M. et al. Integrative pathway enrichment analysis of multivariate omics data. Nat. Commun. 11, 735 (2020).","journal-title":"Nat. Commun."},{"key":"77900_CR42","unstructured":"Jakobsdottir, G. M. et al. Hypoxia spurs evolution of aggressive prostate cancer. Nat. Commun. (2026). [Placeholder reference]."},{"key":"77900_CR43","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molcel.2015.07.026","volume":"59","author":"W Gan","year":"2015","unstructured":"Gan, W. et al. SPOP promotes ubiquitination and degradation of the ERG oncoprotein to suppress prostate cancer progression. Mol. Cell 59, 917\u2013930 (2015).","journal-title":"Mol. Cell"},{"key":"77900_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba3064","volume":"6","author":"B He","year":"2020","unstructured":"He, B. et al. Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. Sci. Adv. 6, eaba3064 (2020).","journal-title":"Sci. Adv."},{"key":"77900_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1158\/2159-8290.CD-23-0467","volume":"14","author":"SP Suehnholz","year":"2024","unstructured":"Suehnholz, S. P. et al. Quantifying the expanding landscape of clinical actionability for patients with cancer. Cancer Discov. 14, 49\u201365 (2024).","journal-title":"Cancer Discov."},{"key":"77900_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng.3774","volume":"49","author":"M Griffith","year":"2017","unstructured":"Griffith, M. et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nat. Genet. 49, 170\u2013174 (2017).","journal-title":"Nat. Genet."},{"key":"77900_CR47","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41379-020-00731-4","volume":"34","author":"TL Lotan","year":"2021","unstructured":"Lotan, T. L. et al. Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer. Mod. Pathol. 34, 1185\u20131193 (2021).","journal-title":"Mod. Pathol."},{"key":"77900_CR48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein, R. M. et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat. Genet. 51, 202\u2013206 (2019).","journal-title":"Nat. Genet."},{"key":"77900_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/srep36772","volume":"6","author":"CK Singh","year":"2016","unstructured":"Singh, C. K. et al. Analysis of zinc-exporters expression in prostate cancer. Sci. Rep. 6, 36772 (2016).","journal-title":"Sci. Rep."},{"key":"77900_CR50","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1038\/sj.onc.1206797","volume":"22","author":"SM Henshall","year":"2003","unstructured":"Henshall, S. M. et al. Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer. Oncogene 22, 6005\u20136012 (2003).","journal-title":"Oncogene"},{"key":"77900_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"Encode Project Consortium","year":"2012","unstructured":"Encode Project Consortium An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"77900_CR52","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1158\/0008-5472.CAN-22-2433","volume":"83","author":"M Li","year":"2023","unstructured":"Li, M. et al. LSD1 inhibition disrupts super-enhancer-driven oncogenic transcriptional programs in castration-resistant prostate cancer. Cancer Res. 83, 1684\u20131698 (2023).","journal-title":"Cancer Res"},{"key":"77900_CR53","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","volume":"174","author":"DA Quigley","year":"2018","unstructured":"Quigley, D. A. et al. Genomic hallmarks and structural variation in metastatic prostate cancer. Cell 174, 758\u2013769.e9 (2018).","journal-title":"Cell"},{"key":"77900_CR54","doi-asserted-by":"crossref","unstructured":"Northcott, P. A. et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511, 428\u2013434 (2014).","DOI":"10.1038\/nature13379"},{"key":"77900_CR55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ng.3722","volume":"49","author":"J Weischenfeldt","year":"2017","unstructured":"Weischenfeldt, J. et al. Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. Nat. Genet. 49, 65\u201374 (2017).","journal-title":"Nat. Genet."},{"key":"77900_CR56","doi-asserted-by":"crossref","unstructured":"Tomlins, S. A. et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448, 595\u2013599 (2007).","DOI":"10.1038\/nature06024"},{"key":"77900_CR57","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41588-018-0154-4","volume":"50","author":"ER Gamazon","year":"2018","unstructured":"Gamazon, E. R. et al. Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation. Nat. Genet. 50, 956\u2013967 (2018).","journal-title":"Nat. Genet."},{"key":"77900_CR58","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"77900_CR59","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA Pan-Cancer Clinical Data Resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416.e11 (2018).","journal-title":"Cell"},{"key":"77900_CR60","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41585-023-00828-w","volume":"21","author":"J Gong","year":"2024","unstructured":"Gong, J. et al. Genetic and biological drivers of prostate cancer disparities in Black men. Nat. Rev. Urol. 21, 274\u2013289 (2024).","journal-title":"Nat. Rev. Urol."},{"key":"77900_CR61","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen, Y., McAndrews, K. M. & Kalluri, R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat. Rev. Clin. Oncol. 18, 792\u2013804 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"77900_CR62","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev, A. et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell 39, 845\u2013865.e7 (2021).","journal-title":"Cancer Cell"},{"key":"77900_CR63","doi-asserted-by":"publisher","unstructured":"Gruber, A. J. et al. Integrated signatures define mutational processes in prostate cancer. Nature https:\/\/doi.org\/10.1038\/s41586-026-10468-w (2026).","DOI":"10.1038\/s41586-026-10468-w"},{"key":"77900_CR64","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2025.01.015","volume":"188","author":"A Khan","year":"2025","unstructured":"Khan, A., Liu, Y., Gad, M., Kenny, T. C. & Birsoy, K. Solute carriers: the gatekeepers of metabolism. Cell 188, 869\u2013884 (2025).","journal-title":"Cell"},{"key":"77900_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09687688.2018.1448123","volume":"34","author":"X Bai","year":"2018","unstructured":"Bai, X., Moraes, T. F. & Reithmeier, R. A. F. Structural biology of solute carrier (SLC) membrane transport proteins. Mol. Membr. Biol. 34, 1\u201332 (2018).","journal-title":"Mol. Membr. Biol."},{"key":"77900_CR66","unstructured":"Fern\u00e1ndez-Sanrom\u00e1n, \u00c1. et al. Evolutionary trajectory and momentum shape prostate cancer outcomes. Nat. Commun. (2026). [Placeholder reference]"},{"key":"77900_CR67","unstructured":"Esent\u00fcrk, E. et al. Causes of evolutionary divergence in prostate cancer. Nat. Commun. (2026). [Placeholder reference]"},{"key":"77900_CR68","unstructured":"Kiriy, D. et al. Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer. Nat. Commun. 17, 9646 (2026)."},{"key":"77900_CR69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","volume":"580","author":"J Li","year":"2020","unstructured":"Li, J. et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature 580, 93\u201399 (2020).","journal-title":"Nature"},{"key":"77900_CR70","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"77900_CR71","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gkj144","volume":"34","author":"AS Hinrichs","year":"2006","unstructured":"Hinrichs, A. S. et al. The UCSC Genome Browser Database: update 2006. Nucleic Acids Res. 34, D590\u2013D598 (2006).","journal-title":"Nucleic Acids Res."},{"key":"77900_CR72","doi-asserted-by":"publisher","first-page":"W193","DOI":"10.1093\/nar\/gkm226","volume":"35","author":"J Reimand","year":"2007","unstructured":"Reimand, J., Kull, M., Peterson, H., Hansen, J. & Vilo, J. g:Profiler-a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 35, W193\u2013W200 (2007).","journal-title":"Nucleic Acids Res."},{"key":"77900_CR73","doi-asserted-by":"crossref","unstructured":"Molania, R. et al. Removing unwanted variation from large-scale RNA sequencing data with PRPS. Nat. Biotechnol. 41, 82\u201395 (2023).","DOI":"10.1038\/s41587-022-01440-w"},{"key":"77900_CR74","doi-asserted-by":"publisher","first-page":"e13984","DOI":"10.1371\/journal.pone.0013984","volume":"5","author":"D Merico","year":"2010","unstructured":"Merico, D., Isserlin, R., Stueker, O., Emili, A. & Bader, G. D. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 5, e13984 (2010).","journal-title":"PLoS One"},{"key":"77900_CR75","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","volume":"14","author":"J Reimand","year":"2019","unstructured":"Reimand, J. et al. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat. Protoc. 14, 482\u2013517 (2019).","journal-title":"Nat. Protoc."},{"key":"77900_CR76","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s43018-022-00356-3","volume":"3","author":"T Chu","year":"2022","unstructured":"Chu, T., Wang, Z., Pe\u2019er, D. & Danko, C. G. Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology. Nat. Cancer 3, 505\u2013517 (2022).","journal-title":"Nat. Cancer"},{"key":"77900_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27322-4","volume":"13","author":"H Song","year":"2022","unstructured":"Song, H. et al. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. Nat. Commun. 13, 141 (2022).","journal-title":"Nat. Commun."},{"key":"77900_CR78","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","volume":"3","author":"B Dong","year":"2020","unstructured":"Dong, B. et al. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer. Commun. Biol. 3, 778 (2020).","journal-title":"Commun. Biol."},{"key":"77900_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00885-z","volume":"13","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis. Genome Med. 13, 81 (2021).","journal-title":"Genome Med."},{"key":"77900_CR80","doi-asserted-by":"publisher","first-page":"110132","DOI":"10.1016\/j.celrep.2021.110132","volume":"37","author":"ZK Tuong","year":"2021","unstructured":"Tuong, Z. K. et al. Resolving the immune landscape of human prostate at a single-cell level in health and cancer. Cell Rep. 37, 110132 (2021).","journal-title":"Cell Rep."},{"key":"77900_CR81","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat. Cell Biol. 23, 87\u201398 (2021).","journal-title":"Nat. Cell Biol."},{"key":"77900_CR82","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.59465","volume":"9","author":"L Crowley","year":"2020","unstructured":"Crowley, L. et al. A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors. Elife 9, e59465 (2020).","journal-title":"Elife"},{"key":"77900_CR83","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2527\/jas2016.94supplement4184x","volume":"94","author":"F Thibaud-Nissen","year":"2016","unstructured":"Thibaud-Nissen, F. et al. P8008 the NCBI Eukaryotic Genome Annotation Pipeline. J. Anim. Sci. 94, 184\u2013184 (2016).","journal-title":"J. Anim. Sci."},{"key":"77900_CR84","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/bioinformatics\/btr064","volume":"27","author":"CE Grant","year":"2011","unstructured":"Grant, C. E., Bailey, T. L. & Noble, W. S. FIMO: scanning for occurrences of a given motif. Bioinformatics 27, 1017\u20131018 (2011).","journal-title":"Bioinformatics"},{"key":"77900_CR85","doi-asserted-by":"publisher","first-page":"D252","DOI":"10.1093\/nar\/gkx1106","volume":"46","author":"IV Kulakovskiy","year":"2018","unstructured":"Kulakovskiy, I. V. et al. HOCOMOCO: towards a complete collection of transcription factor binding models for human and mouse via large-scale ChIP-Seq analysis. Nucleic Acids Res. 46, D252\u2013D259 (2018).","journal-title":"Nucleic Acids Res."},{"key":"77900_CR86","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"77900_CR87","doi-asserted-by":"publisher","unstructured":"Reimand, J. Panprostate\/ppcg-drivers: Pellegrina, Kiriy, Cheng et al. Nat. Commun. https:\/\/doi.org\/10.5281\/ZENODO.22262026 (2026).","DOI":"10.5281\/ZENODO.22262026"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77900-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77900-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77900-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:29:51Z","timestamp":1792150191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77900-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77900"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77900-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"(V.J.G.): Honoraria from Janssen and JEB as a speaker. Member of external expert committee to AstraZeneca UK. (R.A.E.): Honoraria from GU-ASCO, Janssen, University of Chicago, Dana Farber Cancer Institute USA as a speaker. Educational honorarium from Bayer and Ipsen, member of external expert committee to AstraZeneca UK and Member of Active Surveillance Movember Committee. Member of the SAB of Our Future Health. Undertakes private practice as a sole trader at The Royal Marsden NHS Foundation Trust and 90 Sloane Street SW1X 9PQ and 280 Kings Road SW3 4NX, London, UK. (G.M.): co-founder, director and shareholder of Tailor Bio Ltd. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10572"}}